Microcarriers Market Size, Share, Trends, Industry Analysis Report: By Product (Consumables and Equipment), Application, Therapy, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Description

List of Tables

The global microcarriers market size is expected to reach USD 5,230.23 million by 2034, according to a new study by Polaris Market Research. The report "Microcarriers Market Size, Share, Trends, Industry Analysis Report: By Product (Consumables and Equipment), Application, Therapy, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Microcarriers are small, solid, or porous beads that provide a surface for the attachment and growth of adherent cells in suspension-based bioreactors. These tiny particles, made from materials such as polystyrene, dextran, or alginate, allow for high-density cell culture, making them essential in large-scale bioprocessing. By offering a three-dimensional environment for cell proliferation, microcarriers optimize the expansion of cells used in biopharmaceutical production, vaccine development, regenerative medicine, and cell & gene therapy. Their role is critical in industries requiring scalable and efficient cell culture systems, as they enhance productivity while maintaining cell viability and functionality. The microcarriers market size is experiencing significant growth, driven by increasing demand for biologics, vaccines, and cell-based therapies.

Microcarriers Market Report Highlights

By application, biopharmaceutical production held the largest microcarriers market share in 2024, primarily due to the increasing demand for vaccines, monoclonal antibodies, and cell-based therapies. The need for scalable and efficient cell expansion technologies in biologics manufacturing reinforces the segment's dominance.

By therapy, the cell & gene therapy segment held the highest market share in 2024, driven by advancements in regenerative medicine and growing regulatory approvals for innovative cell-based treatments. The rising investment in cell therapy research and manufacturing capacity expansions further support this segment's leadership.

North America held the largest market share in 2024, primarily due to its robust biopharmaceutical industry and substantial investments in cell and gene therapy research.

The microcarriers market key players include Thermo Fisher Scientific Inc.; Merck KGaA; Sartorius AG; Corning Incorporated; Eppendorf SE; Bio-Rad Laboratories, Inc.; HiMedia Laboratories Pvt. Ltd.; denovoMATRIX GmbH; Lonza Group Ltd.; FUJIFILM Holdings Corporation; and BD.

Polaris Market Research has segmented microcarriers market report based on product, application, therapy, and region:

By Product Outlook (Revenue-USD Million, 2020-2034)

Consumables

Equipment

By Application Outlook (Revenue-USD Million, 2020-2034)

Biopharmaceutical Production

Tissue Engineering & Regenerative Medicine

Other Applications

By Therapy Outlook (Revenue-USD Million, 2020-2034)

Cell & Gene Therapy

Tissue Engineering

Others

By Regional Outlook (Revenue-USD Million, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Product Code: PM4360

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Microcarriers Market Insights

4.1. Microcarriers Market - Market Snapshot
4.2. Microcarriers Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Cell Therapy and Regenerative Medicine
  - 4.2.1.2. Rising Incidence of Cancer and Infectious Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Scalability challenges in large-scale bioprocessing
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Microcarriers Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Microcarriers Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Microcarriers Market, by Product, 2020-2034 (USD Million)
5.3. Consumables
- 5.3.1. Global Microcarriers Market, by Consumables, by Region, 2020-2034 (USD Million)
5.4. Equipment
- 5.4.1. Global Microcarriers Market, by Equipment, by Region, 2020-2034 (USD Million)

6. Global Microcarriers Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Microcarriers Market, by Application, 2020-2034 (USD Million)
6.3. Biopharmaceutical Production
- 6.3.1. Global Microcarriers Market, by Biopharmaceutical Production, by Region, 2020-2034 (USD Million)
6.4. Tissue Engineering & Regenerative Medicine
- 6.4.1. Global Microcarriers Market, by Tissue Engineering & Regenerative Medicine, by Region, 2020-2034 (USD Million)
6.5. Other Applications
- 6.5.1. Global Microcarriers Market, by Other Applications, by Region, 2020-2034 (USD Million)

7. Global Microcarriers Market, by Therapy

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Microcarriers Market, by Therapy, 2020-2034 (USD Million)
7.3. Cell & Gene Therapy
- 7.3.1. Global Microcarriers Market, by Cell & Gene Therapy, by Region, 2020-2034 (USD Million)
7.4. Tissue Engineering
- 7.4.1. Global Microcarriers Market, by Tissue Engineering, by Region, 2020-2034 (USD Million)
7.5. Others
- 7.5.1. Global Microcarriers Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Microcarriers Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Microcarriers Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Microcarriers Market - North America
- 8.3.1. North America: Microcarriers Market, by Product, 2020-2034 (USD Million)
- 8.3.2. North America: Microcarriers Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.3.4. Microcarriers Market - U.S.
  - 8.3.4.1. U.S.: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.3.5. Microcarriers Market - Canada
  - 8.3.5.1. Canada: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
8.4. Microcarriers Market - Europe
- 8.4.1. Europe: Microcarriers Market, by Product, 2020-2034 (USD Million)
- 8.4.2. Europe: Microcarriers Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.4. Microcarriers Market - UK
  - 8.4.4.1. UK: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.5. Microcarriers Market - France
  - 8.4.5.1. France: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.5.2. France: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.3. France: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.6. Microcarriers Market - Germany
  - 8.4.6.1. Germany: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.7. Microcarriers Market - Italy
  - 8.4.7.1. Italy: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.8. Microcarriers Market - Spain
  - 8.4.8.1. Spain: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.9. Microcarriers Market - Netherlands
  - 8.4.9.1. Netherlands: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.10. Microcarriers Market - Russia
  - 8.4.10.1. Russia: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.4.11. Microcarriers Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
8.5. Microcarriers Market - Asia Pacific
- 8.5.1. Asia Pacific: Microcarriers Market, by Product, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Microcarriers Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.4. Microcarriers Market - China
  - 8.5.4.1. China: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.4.2. China: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.3. China: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.5. Microcarriers Market - India
  - 8.5.5.1. India: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.5.2. India: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.3. India: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.6. Microcarriers Market - Malaysia
  - 8.5.6.1. Malaysia: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.7. Microcarriers Market - Japan
  - 8.5.7.1. Japan: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.8. Microcarriers Market - Indonesia
  - 8.5.8.1. Indonesia: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.9. Microcarriers Market - South Korea
  - 8.5.9.1. South Korea: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.10. Microcarriers Market - Australia
  - 8.5.10.1. Australia: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.5.11. Microcarriers Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
8.6. Microcarriers Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Microcarriers Market, by Product, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Microcarriers Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.6.4. Microcarriers Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.6.5. Microcarriers Market - UAE
  - 8.6.5.1. UAE: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.6.6. Microcarriers Market - Israel
  - 8.6.6.1. Israel: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.6.7. Microcarriers Market - South Africa
  - 8.6.7.1. South Africa: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.6.8. Microcarriers Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
8.7. Microcarriers Market - Latin America
- 8.7.1. Latin America: Microcarriers Market, by Product, 2020-2034 (USD Million)
- 8.7.2. Latin America: Microcarriers Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.7.4. Microcarriers Market - Mexico
  - 8.7.4.1. Mexico: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.7.5. Microcarriers Market - Brazil
  - 8.7.5.1. Brazil: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.7.6. Microcarriers Market - Argentina
  - 8.7.6.1. Argentina: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Microcarriers Market, by Therapy, 2020-2034 (USD Million)
- 8.7.7. Microcarriers Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Microcarriers Market, by Product, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Microcarriers Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Microcarriers Market, by Therapy, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. BD
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Bio-Rad Laboratories, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Corning Incorporated
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Danaher Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. denovoMATRIX GmbH
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Eppendorf SE
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. FUJIFILM Holdings Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. HiMedia Laboratories Pvt. Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Lonza Group Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Merck KGaA
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Sartorius AG
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Thermo Fisher Scientific Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development